Literature DB >> 992869

Fate of rubella genome ribonucleic acid after immune and nonimmune virolysis in the presence of ribonuclease.

A Schluederberg, C Ajello, B Evans.   

Abstract

To determine whether rubella virion ribonucleic acid (RNA) becomes accessible to nuclease attack after immune lysis of the viral envelope, virions containing radioactively labeled RNA were examined in three ways with the following results. (i) Incubation of purified virus with heat-inactivated rubella convalescent human serum and guinea pig complement resulted in an increase in acid-soluble RNA. Antibody was required; the reaction was temperature dependent and was blocked by ethylenediaminetetraacetic acid. When exogenous nuclease was added prior to lysis, radioactivity in virions was reduced to 15% of that in unlysed control pellets (ii) Sucrose gradient sedimentation profiles of RNA released from lysed and unlysed virions under controlled conditions showed that the nuclease content of serum-virus mixtures was sufficient to eliminate all RNA of genome size, although degradation was not complete. (iii) Virions were also lysed by unheated human immune sera in the absence of guinea pig complement and by some, but not all, unheated antibody-negative sera.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 992869      PMCID: PMC415497          DOI: 10.1128/iai.14.4.1097-1102.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  LESIONS IN ERYTHROCYTE MEMBRANES CAUSED BY IMMUNE HAEMOLYSIS.

Authors:  T BORSOS; R R DOURMASHKIN; J H HUMPHREY
Journal:  Nature       Date:  1964-04-18       Impact factor: 49.962

2.  Ribonuclease in normal and uraemic human blood.

Authors:  J H CONNOLLY; R M HERRIOTT; S GUPTA
Journal:  Br J Exp Pathol       Date:  1962-08

3.  Deoxyribonuclease in human blood and platelets.

Authors:  J H CONNOLLY; R M HERRIOTT; S GUPTA
Journal:  Br J Exp Pathol       Date:  1962-08

4.  Blood nucleases and infectious viral nucleic acids.

Authors:  R M HERRIOTT; J H CONNOLLY; S GUPTA
Journal:  Nature       Date:  1961-03-11       Impact factor: 49.962

5.  Human serum lyses RNA tumour viruses.

Authors:  R M Welsh; N R Cooper; F C Jensen; M B Oldstone
Journal:  Nature       Date:  1975-10-16       Impact factor: 49.962

6.  Immune virolysis: effect of antibody and complement on C-type RNA virus.

Authors:  S Oroszlan; R V Gilden
Journal:  Science       Date:  1970-06-19       Impact factor: 47.728

7.  The fate of sensitized equine arteritis virus following neutralization by complement of anti-IgG serum.

Authors:  A I Radwan; D Burger; W C Davis
Journal:  Virology       Date:  1973-06       Impact factor: 3.616

8.  Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin.

Authors:  M H Kaplan; J E Volanakis
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

9.  The morphology of virus-antibody interaction.

Authors:  J D Almeida; A P Waterson
Journal:  Adv Virus Res       Date:  1969       Impact factor: 9.937

10.  Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera.

Authors:  J Siegel; R Rent; H Gewurz
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.